Central Trust Company’s LifeVantage LFVN Stock Holding History

Central Trust Company’s Portfolio LFVN Stock Details LFVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-72	Closed	–	–	1178
2016 Q4	$0	Buy	+72	New	+$616	﹤0.01%	1183

Other funds holding LFVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Central Trust Company's LFVN Position: Q1 2017 in Review

Central Trust Company sold out of LifeVantage (LFVN) in Q1 2017, closing a stake of 72 shares.

Central Trust Company first reported a position in LFVN in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 73 funds tracked by Wall St. Rank hold LFVN as of Q1 2017.

Central Trust Company reported no remaining LifeVantage position as of Q1 2017 after selling out during the quarter.
Central Trust Company sold 72 LifeVantage shares in Q1 2017.
Central Trust Company first reported a position in LifeVantage in Q4 2016 and held it in 1 quarter.
Central Trust Company's LifeVantage position peaked at $0 in Q4 2016.
73 funds tracked by Wall St. Rank held LifeVantage as of Q1 2017.

Based on Central Trust Company's 13F filing for Q1 2017, filed 6 Apr 2017.